Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
20.85
+0.71 (3.53%)
Jun 12, 2026, 4:00 PM EDT - Market closed

KMTS Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, KMTS stock has a consensus rating of "Strong Buy" and an average price target of $27.71. The average 1-year stock price forecast is 32.90% higher than the current stock price, while the lowest is $17 (-18.47%) and the highest is $30 (+43.88%).

Price Target: $27.71 (+32.90%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$17$27.71$30$30
Change-18.47%+32.90%+43.88%+43.88%
* Price targets were last updated on May 11, 2026.

Analyst Ratings

The average analyst rating for KMTS stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingNov '25Dec '25Jan '26Mar '26Apr '26May '26
Strong Buy555555
Buy111110
Hold111111
Sell000000
Strong Sell000000
Total777776

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Piper Sandler
Piper Sandler
Buy
Maintains
$30
BuyMaintains$30+43.88%May 11, 2026
BTIG
BTIG
Buy
Maintains
$32$30
BuyMaintains$32$30+43.88%Apr 13, 2026
Goldman Sachs
Goldman Sachs
Hold
Reiterates
$22$17
HoldReiterates$22$17-18.47%Apr 8, 2026
Bank of America Securities
Bank of America Securities
Buy
Maintains
n/a
BuyMaintainsn/an/aMar 18, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Maintains
$30
BuyMaintains$30+43.88%Mar 18, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
92.97M
from 59.82M
Increased by 55.43%
Revenue Next Year
132.90M
from 92.97M
Increased by 42.94%
EPS This Year
-2.33
from -3.91
EPS Next Year
-2.14
from -2.33
Fiscal YearFY 2020FY 2021FY 2023FY 2024FY 2025FY 2026
Period EndingApr 30, 2020Apr 30, 2021Apr 30, 2023Apr 30, 2024Apr 30, 2025Apr 30, 2026
Revenue
--7.63M27.81M59.82M92.97M
Revenue Growth
---264.54%115.05%55.43%
Gross Profit
---10.65M362.00K24.21M47.17M
Gross Margin
---139.59%1.30%40.47%50.74%
Operating Income
-29.32M-32.71M-80.42M-85.06M-106.38M-129.50M
Net Income
-29.47M-34.10M-84.24M-94.12M-113.81M-126.63M
EPS
-----3.91-2.33
Free Cash Flow
--18.53M--40.92M-67.53M-126.55M
No. Analysts
-----7
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High93.1M
Avg93.0M
Low92.8M

Revenue Growth

Revenue Growth202620272028
High
55.6%
Avg
55.4%
Low
55.2%

EPS Forecast

EPS202620272028
High-2.30
Avg-2.33
Low-2.36

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-